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This will be a quasi-experimental study design with 
a goal of 60 patients about to undergo surgical or 
invasive procedures requiring an IV catheter 
insertion in the pre op department at West Kendall 
Baptist Hospital (WKBH).
Patient who receive, as standard of practice, 1% 
licocaine prior to IV insertion Will be compared to 
those that did not.
The study sample will consist of 60 patients aged 18 
years and older
To be included in the study participants have to 
have IV accesses established, and the ability to 
express their pain level.
The data collection tool of the study will consist of a 
questionnaire that include patient demographic 
information and questions about pain perception 
and anxiety experienced with IV insertion.
Eligible patients will be introduce to the study with a 
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It is critical for sepsis screening to be 
implemented and studied to identify possible 
sepsis in the pediatric population. Currently 
many acute care settings use an adult based 
screening tool for all populations. This study 
proposed that a new pediatric specific sepsis 
screen should be utilized in comparison with 
the previous tool to address the need for 
improving identification of sepsis. Therefore, 
the specific purpose of this study is to 
determine if the implementation of an 
evidence-based, pediatric specific sepsis 
screening tool improved the identification of 
sepsis in pediatric emergency department 
patients.
Data was collected retrospectively from 
sample of 0-17 years old, receiving a 
diagnosis of sepsis, and treated within 
Baptist Health South Florida between Oct. 
2014-Oct.2015. The electronic medical 
record screen and the Pediatric Sepsis ACT 
tool were used to determine positive and 
negative values of sepsis. Time of antibiotic 
administration along with IVF bolus with type 
was collected. Laboratory studies, including 
blood cultures, procalcitonin, lactic acid, 
WBC, and CRP were collected.
There were a total of 520 pediatric patients 
with a discharg  diagnosis of Sepsis in the 
three hospitals studi d. The age ranged fr m 
12 days to 17 years old. In total, at least one 
screening method used for 417 of the 520 
(80.2%) sepsis patients and 26.6% of those 
417 patients had a positive result indicating 
a low sensitivity of the screening process. 
Only 40% of patients receiving antibiotics 
had blood cultures collected prior to 
medication administration with 27% 
receiving intravenous fluids. 50% of the 
patients had white blood cells measured. 
Furthermore, the ACT part 1 screening tool 
revealed 26% of those screened having a 
positive result. This is in comparison to only 
24% of the patients screened with the t-
system tool.
Our findings suggest that many of the 
pediatric patients diagnosed with sepsis do 
not fall into a category of severe sepsis in 
need of aggressive lab and fluid treatment. 
This may be the cause for less than half of 
patients receiving blood cultures prior to 
administration of antibiotics and minimal 
collection of lab values. Findings also 
demonstrated compliance issues from 
nurses with about 1 of 5 patients not 
receiving screening.
Nurses must be vigilant in screening the 
pediatric population for sepsis. No significant 
difference found between two screening 
tools, however, it is recommended for 
improvements to ensure proper compliance 
of screening for at-risk pediatric patients. 
